Does insurance cover Zepbound for weight loss?

Verified Sep 2026 · re-checked monthlyBy the GLP1Zoom editorial teamWe compare, we don’t sell

Short answer

Some commercial plans cover Zepbound for weight loss (often with prior authorization and a BMI requirement), Medicare covers it only for the obstructive-sleep-apnea indication, and Medicaid coverage varies by state.

Coverage depends on your plan. A growing number of commercial (employer/marketplace) plans cover Zepbound for chronic weight management, but most require prior authorization and a qualifying BMI (typically ≥30, or ≥27 with a weight-related condition). Check your plan’s formulary and PA criteria.

Medicare Part D can cover Zepbound for its FDA-approved obstructive sleep apnea indication. For weight management, eligible Part D members can get the Zepbound KwikPen through the Medicare GLP-1 Bridge — a flat $50/month from July 1, 2026 to December 31, 2027 for Wegovy (pen or pill), Zepbound KwikPen and Foundayo. Medicaid coverage varies by state. If you are not covered, Lilly self-pay (vial or KwikPen) runs $299–$699/month depending on dose and refill timing. Confirm current coverage with your insurer.

Zepbound coverage by type of insurance

Your insurance	Coverage	What you pay
Commercial plan that covers Zepbound	Covered, usually with prior authorization and a BMI requirement	As little as $25 with the Zepbound Savings Card (up to $100 off per 1-month fill, $1,300 a year)
Commercial plan that excludes weight-loss drugs	Not covered for weight; the sleep apnea indication may still be covered	As low as $499 per 1-month pen fill with Lilly’s card for non-covered patients, or Lilly self-pay
Medicare Part D	Sleep apnea indication through your plan; weight management through the GLP-1 Bridge if you qualify	$50/month under the Bridge; plan cost-sharing for sleep apnea
Medicaid	Depends on your state	Your state’s copay
No insurance	None	Lilly self-pay: $299 at 2.5 mg up to $699 at 10–15 mg if you miss the 45-day refill window

How to check your own plan

Find Zepbound on your plan’s formulary and note its tier and whether it needs prior authorization.
Ask whether your plan excludes weight-loss drugs as a benefit. An exclusion is not a clinical decision, and medical evidence does not overturn it.
If you have moderate-to-severe obstructive sleep apnea with obesity, ask your prescriber about the sleep apnea indication, which plans cover separately.
If you are denied for a clinical reason, ask for the plan’s criteria in writing and appeal.

What catches people out

A benefit exclusion and a clinical denial look alike on the letter. An appeal can win only the second.
The Medicare GLP-1 Bridge excludes people who already have a covered GLP-1 indication — type 2 diabetes, sleep apnea or noncirrhotic fatty liver disease — and people who filled a GLP-1 under Part D in 2026.

References(1)

Our sourcing standards →

Medicare Part D drug coverage — Medicare.gov

GLP-1 insurance coverage by payer

Related questions

Educational only, not medical advice. GLP1Zoom is an independent comparison site, not a pharmacy. Prices are estimates as of September 2026, and prices and coverage change without notice; compounded products are not FDA-approved as finished drugs. Full disclaimer.

Zepbound coverage by type of insurance

Your insurance	Coverage	What you pay
Commercial plan that covers Zepbound	Covered, usually with prior authorization and a BMI requirement	As little as $25 with the Zepbound Savings Card (up to $100 off per 1-month fill, $1,300 a year)
Commercial plan that excludes weight-loss drugs	Not covered for weight; the sleep apnea indication may still be covered	As low as $499 per 1-month pen fill with Lilly’s card for non-covered patients, or Lilly self-pay
Medicare Part D	Sleep apnea indication through your plan; weight management through the GLP-1 Bridge if you qualify	$50/month under the Bridge; plan cost-sharing for sleep apnea
Medicaid	Depends on your state	Your state’s copay
No insurance	None	Lilly self-pay: $299 at 2.5 mg up to $699 at 10–15 mg if you miss the 45-day refill window

How to check your own plan

Find Zepbound on your plan’s formulary and note its tier and whether it needs prior authorization.

Ask whether your plan excludes weight-loss drugs as a benefit. An exclusion is not a clinical decision, and medical evidence does not overturn it.

If you have moderate-to-severe obstructive sleep apnea with obesity, ask your prescriber about the sleep apnea indication, which plans cover separately.

If you are denied for a clinical reason, ask for the plan’s criteria in writing and appeal.

What catches people out

A benefit exclusion and a clinical denial look alike on the letter. An appeal can win only the second.

The Medicare GLP-1 Bridge excludes people who already have a covered GLP-1 indication — type 2 diabetes, sleep apnea or noncirrhotic fatty liver disease — and people who filled a GLP-1 under Part D in 2026.